Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 3:17 PM View:  | Entegris Inc. (ENTG) | 01-Apr-24 | Grant | 38,208 | -- | -- | 17% 224.86K to 263.07K | |
| 21-Feb-24 10:00 PM View: | Entegris Inc. (ENTG) | 20-Feb-24 | Grant | 20,534 | -- | -- | 10% 213.43K to 233.97K | |
| 21-Feb-24 10:00 PM View: | Entegris Inc. (ENTG) | 20-Feb-24 | Payment of Exercise | 9,107 | $136.81 | $1,245,930.00 | (4%) 233.97K to 224.86K | |
| 21-Feb-24 10:00 PM View: | Entegris Inc. (ENTG) | 16-Feb-24 | Payment of Exercise | 15,756 | $136.81 | $2,155,580.00 | (7%) 229.19K to 213.43K | 2% |
| 17-Aug-23 4:27 PM View: | Entegris Inc. (ENTG) | 15-Aug-23 | Payment of Exercise | 9,357 | $95.87 | $897,056.00 | (4%) 238.55K to 229.19K | |
| 23-May-23 4:03 PM View: | Harvard Bioscience Inc. (HBIO) | 22-May-23 | Grant | 31,516 | -- | -- | 7% 468.12K to 499.63K | |
| 21-Feb-23 4:02 PM View: | Entegris Inc. (ENTG) | 17-Feb-23 | Payment of Exercise | 14,126 | $85.48 | $1,207,490.00 | (6%) 252.67K to 238.55K | |
| 15-Feb-23 4:05 PM View: | Entegris Inc. (ENTG) | 13-Feb-23 | Grant | 19,676 | -- | -- | 8% 241.72K to 261.4K | |
| 15-Feb-23 4:05 PM View: | Entegris Inc. (ENTG) | 13-Feb-23 | Payment of Exercise | 8,727 | $84.94 | $741,271.00 | (3%) 261.4K to 252.67K | |
| 02-Feb-23 4:08 PM View: | Entegris Inc. (ENTG) | 31-Jan-23 | Grant | 51,292 | -- | -- | 27% 190.43K to 241.72K | |
| 15-Sep-22 4:02 PM View: | Harvard Bioscience Inc. (HBIO) | 06-Sep-22 | Disposition (other) | 108,715 | -- | -- | (19%) 576.83K to 468.12K | |
| 29-Aug-22 5:24 PM View: | Harvard Bioscience Inc. (HBIO) | 26-Aug-22 | Private Purchase | 9,291 | $3.41 | $31,682.30 | 2% 458.83K to 468.12K | |
| 26-Aug-22 4:02 PM View: | Harvard Bioscience Inc. (HBIO) | 25-Aug-22 | Purchase | 8,244 | $3.34 | $27,535.00 | 2% 450.58K to 458.83K | |
| 26-Aug-22 4:02 PM View: | Harvard Bioscience Inc. (HBIO) | 24-Aug-22 | Private Purchase | 17,291 | $3.23 | $55,849.90 | 4% 433.29K to 450.58K | |
| 24-Aug-22 4:06 PM View: | Harvard Bioscience Inc. (HBIO) | 23-Aug-22 | Purchase | 8,939 | $3.23 | $28,873.00 | 2% 424.35K to 433.29K | |
| 24-Aug-22 4:06 PM View: | Harvard Bioscience Inc. (HBIO) | 22-Aug-22 | Private Purchase | 4,918 | $3.16 | $15,540.90 | 1% 419.43K to 424.35K | |
| 22-Aug-22 4:08 PM View: | Harvard Bioscience Inc. (HBIO) | 19-Aug-22 | Purchase | 9,608 | $3.28 | $31,514.20 | 2% 409.83K to 419.43K | |
| 22-Aug-22 4:08 PM View: | Harvard Bioscience Inc. (HBIO) | 18-Aug-22 | Private Purchase | 1,151 | $3.19 | $3,671.69 | < 1% 408.68K to 409.83K | |
| 17-Aug-22 4:08 PM View: | Entegris Inc. (ENTG) | 15-Aug-22 | Payment of Exercise | 9,357 | $105.39 | $986,134.00 | (5%) 199.79K to 190.43K | |
| 08-Jul-22 4:43 PM View: | Entegris Inc. (ENTG) | 06-Jul-22 | Grant | 116 | -- | -- | < 1% 199.67K to 199.79K | |
| 26-May-22 10:00 PM View: | Harvard Bioscience Inc. (HBIO) | 24-May-22 | Grant | 47,493 | -- | -- | 13% 361.18K to 408.68K | |
| 23-Feb-22 4:12 PM View: | Entegris Inc. (ENTG) | 18-Feb-22 | Payment of Exercise | 15,043 | $130.19 | $1,958,450.00 | (7%) 214.72K to 199.67K | (3%) |
| 15-Feb-22 4:07 PM View: | Entegris Inc. (ENTG) | 11-Feb-22 | Grant | 24,020 | -- | -- | 12% 201.35K to 225.37K | |
| 15-Feb-22 4:07 PM View: | Entegris Inc. (ENTG) | 11-Feb-22 | Payment of Exercise | 10,653 | $124.48 | $1,326,090.00 | (5%) 225.37K to 214.72K | |
| 03-Feb-22 4:21 PM View: | Entegris Inc. (ENTG) | 01-Feb-22 | Grant | 27,248 | -- | -- | 16% 174.1K to 201.35K | |
| 03-Jan-22 7:51 PM View: | Harvard Bioscience Inc. (HBIO) | 01-Jan-22 | Grant | 4,489 | -- | -- | 1% 356.69K to 361.18K | |
| 29-Dec-21 4:22 PM View: | Harvard Bioscience Inc. (HBIO) | 28-Dec-21 | Grant | 1,401 | -- | -- | < 1% 355.29K to 356.69K | |
| 13-Aug-21 4:02 PM View: | Entegris Inc. (ENTG) | 11-Aug-21 | Market Sale | 23,710 | $116.66 | $2,766,020.00 | (100%) 23.71K to 0 | 3% |
| 06-Aug-21 4:08 PM View: | Entegris Inc. (ENTG) | 04-Aug-21 | Market Sale | 17,000 | $125.42 | $2,132,100.00 | (4%) 393.79K to 376.79K | 3% |
| 06-Aug-21 4:08 PM View: | Entegris Inc. (ENTG) | 04-Aug-21 | Market Sale | 39,178 | $125.44 | $4,914,660.00 | (10%) 376.79K to 337.62K | 3% |
| 27-May-21 4:17 PM View: | Harvard Bioscience Inc. (HBIO) | 25-May-21 | Grant | 14,400 | -- | -- | 4% 340.89K to 355.29K | |
| 14-Apr-21 7:01 PM View: | Entegris Inc. (ENTG) | 14-Apr-21 | Market Sale (Planned) | 100,000 | $118.43 | $11,843,000.00 | (20%) 493.79K to 393.79K | < 1% |
| 14-Apr-21 7:01 PM View: | Entegris Inc. (ENTG) | 13-Apr-21 | Market Sale (Planned) | 100,000 | $117.96 | $11,796,100.00 | (17%) 593.79K to 493.79K | (< 1%) |
| 14-Apr-21 7:01 PM View: | Entegris Inc. (ENTG) | 12-Apr-21 | Market Sale (Planned) | 100,000 | $119.36 | $11,935,700.00 | (14%) 693.79K to 593.79K | < 1% |
| 07-Apr-21 4:08 PM View: | Entegris Inc. (ENTG) | 05-Apr-21 | Option Exercise | 300,444 | $28.88 | $8,677,750.00 | 43% 693.79K to 994.24K | |
| 07-Apr-21 4:08 PM View: | Entegris Inc. (ENTG) | 05-Apr-21 | Market Option Sale (Planned) | 300,444 | $120.69 | $36,259,800.00 | (30%) 994.24K to 693.79K | |
| 23-Feb-21 4:10 PM View: | Entegris Inc. (ENTG) | 19-Feb-21 | Grant | 23,428 | -- | -- | 3% 697.53K to 720.96K | |
| 23-Feb-21 4:10 PM View: | Entegris Inc. (ENTG) | 19-Feb-21 | Payment of Exercise | 27,165 | $105.57 | $2,867,810.00 | (4%) 720.96K to 693.79K | |
| 04-Feb-21 4:16 PM View: | Entegris Inc. (ENTG) | 02-Feb-21 | Grant | 29,760 | -- | -- | 4% 667.77K to 697.53K | |
| 06-Jan-21 5:50 PM View: | Harvard Bioscience Inc. (HBIO) | 04-Jan-21 | Grant | 21,300 | -- | -- | 7% 319.59K to 340.89K | |
| 10-Sep-20 4:01 PM View: | Entegris Inc. (ENTG) | 08-Sep-20 | Gift | 101,888 | -- | -- | 15% 667.77K to 769.66K | |
| 10-Sep-20 4:01 PM View: | Entegris Inc. (ENTG) | 08-Sep-20 | Gift | 101,888 | -- | -- | (13%) 769.66K to 667.77K | |
| 03-Aug-20 4:05 PM View: | Entegris Inc. (ENTG) | 31-Jul-20 | Market Option Sale | 118,520 | $71.79 | $8,509,150.00 | (15%) 786.29K to 667.77K | (33%) |
| 03-Aug-20 4:05 PM View: | Entegris Inc. (ENTG) | 30-Jul-20 | Payment of Exercise | 139,408 | $70.00 | $9,758,560.00 | (15%) 925.7K to 786.29K | (37%) |
| 03-Aug-20 4:05 PM View: | Entegris Inc. (ENTG) | 30-Jul-20 | Option Exercise | 257,928 | $12.20 | $3,146,720.00 | 39% 667.77K to 925.7K | |
| 31-Jul-20 5:22 PM View: | Entegris Inc. (ENTG) | 29-Jul-20 | Grant | 42,194 | -- | -- | 7% 625.58K to 667.77K | |
| 28-Jul-20 4:25 PM View: | Entegris Inc. (ENTG) | 27-Jul-20 | Market Option Sale (Planned) | 75,943 | $69.64 | $5,288,890.00 | (11%) 701.52K to 625.58K | (37%) |
| 28-Jul-20 4:25 PM View: | Entegris Inc. (ENTG) | 24-Jul-20 | Payment of Exercise | 95,045 | $67.44 | $6,409,840.00 | (12%) 796.57K to 701.52K | (42%) |
| 28-Jul-20 4:25 PM View: | Entegris Inc. (ENTG) | 24-Jul-20 | Option Exercise | 170,988 | $13.49 | $2,306,630.00 | 27% 625.58K to 796.57K | |
| 02-Jul-20 7:06 PM View: | Harvard Bioscience Inc. (HBIO) | 01-Jul-20 | Grant | 1,300 | -- | -- | < 1% 318.29K to 319.59K |